OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Interindividual Variability of Carboxymethylenebutenolidase Homolog, a Novel Olmesartan Medoxomil Hydrolase, in the Human Liver and Intestine
Tomoko Ishizuka, Veronika Rozehnal, Thomas M. Fischer, et al.
Drug Metabolism and Disposition (2013) Vol. 41, Iss. 5, pp. 1156-1162
Closed Access | Times Cited: 13
Tomoko Ishizuka, Veronika Rozehnal, Thomas M. Fischer, et al.
Drug Metabolism and Disposition (2013) Vol. 41, Iss. 5, pp. 1156-1162
Closed Access | Times Cited: 13
Showing 13 citing articles:
Identifying Methylation Pattern and Genes Associated with Breast Cancer Subtypes
Lei Chen, Tao Zeng, Xiaoyong Pan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4269-4269
Open Access | Times Cited: 50
Lei Chen, Tao Zeng, Xiaoyong Pan, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 17, pp. 4269-4269
Open Access | Times Cited: 50
Sequential liquid-liquid extraction coupled to LC-MS/MS for simultaneous determination of amlodipine, olmesartan and hydrochlorothiazide in plasma samples: Application to pharmacokinetic studies
Ehab F. Elkady, Asmaa A. Mandour, Faisal K. Algethami, et al.
Microchemical Journal (2020) Vol. 155, pp. 104757-104757
Closed Access | Times Cited: 25
Ehab F. Elkady, Asmaa A. Mandour, Faisal K. Algethami, et al.
Microchemical Journal (2020) Vol. 155, pp. 104757-104757
Closed Access | Times Cited: 25
Different Hydrolases Involved in Bioactivation of Prodrug-Type Angiotensin Receptor Blockers: Carboxymethylenebutenolidase and Carboxylesterase 1
Tomoko Ishizuka, Yasushi Yoshigae, Nobuyuki Murayama, et al.
Drug Metabolism and Disposition (2013) Vol. 41, Iss. 11, pp. 1888-1895
Closed Access | Times Cited: 29
Tomoko Ishizuka, Yasushi Yoshigae, Nobuyuki Murayama, et al.
Drug Metabolism and Disposition (2013) Vol. 41, Iss. 11, pp. 1888-1895
Closed Access | Times Cited: 29
p53-responsive CMBL reprograms glucose metabolism and suppresses cancer development by destabilizing phosphofructokinase PFKP
Yingdan Huang, Xiong Chen, Chunmeng Wang, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113426-113426
Open Access | Times Cited: 8
Yingdan Huang, Xiong Chen, Chunmeng Wang, et al.
Cell Reports (2023) Vol. 42, Iss. 11, pp. 113426-113426
Open Access | Times Cited: 8
Chemoproteomic Identification of Serine Hydrolase RBBP9 as a Valacyclovir-Activating Enzyme
Vikram M. Shenoy, Brian R. Thompson, Jian Shi, et al.
Molecular Pharmaceutics (2020) Vol. 17, Iss. 5, pp. 1706-1714
Closed Access | Times Cited: 18
Vikram M. Shenoy, Brian R. Thompson, Jian Shi, et al.
Molecular Pharmaceutics (2020) Vol. 17, Iss. 5, pp. 1706-1714
Closed Access | Times Cited: 18
Coupling of an Acyl Migration Prodrug Strategy with Bio-activation To Improve Oral Delivery of the HIV-1 Protease Inhibitor Atazanavir
Murugaiah A. M. Subbaiah, Nicholas A. Meanwell, John F. Kadow, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 9, pp. 4176-4188
Closed Access | Times Cited: 13
Murugaiah A. M. Subbaiah, Nicholas A. Meanwell, John F. Kadow, et al.
Journal of Medicinal Chemistry (2018) Vol. 61, Iss. 9, pp. 4176-4188
Closed Access | Times Cited: 13
Taxonomic and evolutionary insights from comparative genomics of hydrocarbon degrading bacteria isolated from petroleum reservoirs
Alejandra Calderon-Fajardo, Kelly Hidalgo, Erika A. Valoni Romao, et al.
Journal of Hazardous Materials Advances (2024) Vol. 15, pp. 100439-100439
Open Access | Times Cited: 1
Alejandra Calderon-Fajardo, Kelly Hidalgo, Erika A. Valoni Romao, et al.
Journal of Hazardous Materials Advances (2024) Vol. 15, pp. 100439-100439
Open Access | Times Cited: 1
Factors influencing hepatic metabolism of antihypertensive drugs: impact on clinical response
Christián Höcht, Facundo M. Bertera, Yanina Santander Plantamura, et al.
Expert Opinion on Drug Metabolism & Toxicology (2018) Vol. 15, Iss. 1, pp. 1-13
Closed Access | Times Cited: 10
Christián Höcht, Facundo M. Bertera, Yanina Santander Plantamura, et al.
Expert Opinion on Drug Metabolism & Toxicology (2018) Vol. 15, Iss. 1, pp. 1-13
Closed Access | Times Cited: 10
Evaluation of anti-inflammatory, immunomodulatory effects and celiac-like side effect of olmesartan medoxomil as a vitamin D receptor agonist and angiotensin II receptor blocker
Yelda Komesli, H. Yeşim Karasulu
Journal of Research in Pharmacy (2021) Vol. 26(1), Iss. 26(1), pp. 1080-1091
Open Access | Times Cited: 4
Yelda Komesli, H. Yeşim Karasulu
Journal of Research in Pharmacy (2021) Vol. 26(1), Iss. 26(1), pp. 1080-1091
Open Access | Times Cited: 4
Identification of non-P450 enzymes involved in the metabolism of new drugs: Their significance in drug interaction evaluation and prodrug disposition
Yumi Nishiya, Eiko Suzuki, Tomoko Ishizuka, et al.
Drug Metabolism and Pharmacokinetics (2019) Vol. 35, Iss. 1, pp. 45-55
Closed Access | Times Cited: 3
Yumi Nishiya, Eiko Suzuki, Tomoko Ishizuka, et al.
Drug Metabolism and Pharmacokinetics (2019) Vol. 35, Iss. 1, pp. 45-55
Closed Access | Times Cited: 3
Comments on: “Population Pharmacokinetic Modeling of Olmesartan, the Active Metabolite of Olmesartan Medoxomil, in Patients with Hypertension”
Nuggehally R. Srinivas
European Journal of Drug Metabolism and Pharmacokinetics (2017) Vol. 42, Iss. 6, pp. 1019-1021
Closed Access | Times Cited: 1
Nuggehally R. Srinivas
European Journal of Drug Metabolism and Pharmacokinetics (2017) Vol. 42, Iss. 6, pp. 1019-1021
Closed Access | Times Cited: 1
Bioconversion of the prodrug olmesartan medoxomil via carboxymethylene- butenolidase and paraoxonase 1
智子 石塚, トモコ イシヅカ, Tomoko Ishizuka
(2014)
Closed Access
智子 石塚, トモコ イシヅカ, Tomoko Ishizuka
(2014)
Closed Access
ANGIOTENSIN RECEPTOR ANTAGONISTS: GOING WITH THE TIMES
Е. О. Таратухин
CARDIOVASCULAR THERAPY AND PREVENTION (2013) Vol. 12, Iss. 3, pp. 55-57
Open Access
Е. О. Таратухин
CARDIOVASCULAR THERAPY AND PREVENTION (2013) Vol. 12, Iss. 3, pp. 55-57
Open Access
